All In Biotech

Free tool

FAERS Monitor: Isolyte S In Plastic Container

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 019711 or its brand name (Isolyte S In Plastic Container, Magnesium Chloride, Potassium Chloride, Sodium Acetate, Sodium Chloride, Sodium Gluconate). Reports on generic versions are filed under their own applications.

Reports

6

Serious

5

83% of reports

Hospitalization

2

Death reported

0

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • haemorrhage intracranial2
  • anxiety1
  • atrial fibrillation1
  • auditory disorder1
  • blood glucose increased1
  • concomitant disease aggravated1
  • convulsion1
  • deafness permanent1
  • disability1
  • discomfort1
  • dry eye1
  • ear dryness1
  • economic problem1
  • emotional distress1
  • hypotension1

Reports by year received

View as table
YearReports
20112
20181
20231
20242

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,153 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
ear dryness133740.65580.08,354
deafness permanent117995.02990.34,475
auditory disorder12472.9412.9617
concomitant disease aggravated1568.194.9141
haemorrhage intracranial2469.0151.2525
economic problem1231.338.657
disability1177.329.643
dry eye170.211.717
convulsion161.310.214
discomfort157.59.613
atrial fibrillation136.06.08
emotional distress129.04.86
blood glucose increased118.63.14
hypotension117.52.93
anxiety112.32.12

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.